{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:37:57Z","timestamp":1790642277248,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS063967"],"award-info":[{"award-number":["NS063967"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS007222"],"award-info":[{"award-number":["NS007222"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM007767"],"award-info":[{"award-number":["GM007767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL125242"],"award-info":[{"award-number":["HL125242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001790","name":"Parseghian Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001790","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"crossref","award":["N.A."],"award-info":[{"award-number":["N.A."]}],"id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Niemann-Pick Canada","award":["N.A."],"award-info":[{"award-number":["N.A."]}]},{"name":"Hope for Marion","award":["None"],"award-info":[{"award-number":["None"]}]},{"name":"University of Michigan Protein Folding Diseases Initiative","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Niemann\u2013Pick disease type C is a fatal and progressive neurodegenerative disorder characterized by the accumulation of unesterified cholesterol in late endosomes and lysosomes. We sought to develop new therapeutics for this disorder by harnessing the body\u2019s endogenous cholesterol scavenging particle, high-density lipoprotein (HDL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here we design, optimize, and define the mechanism of action of synthetic HDL (sHDL) nanoparticles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We demonstrate a dose-dependent rescue of cholesterol storage that is sensitive to sHDL lipid and peptide composition, enabling the identification of compounds with a range of therapeutic potency. Peripheral administration of sHDL to\n                      <jats:italic>Npc1 I1061T<\/jats:italic>\n                      homozygous mice mobilizes cholesterol, reduces serum bilirubin, reduces liver macrophage size, and corrects body weight deficits. Additionally, a single intraventricular injection into adult\n                      <jats:italic>Npc1 I1061T<\/jats:italic>\n                      brains significantly reduces cholesterol storage in Purkinje neurons. Since endogenous HDL is also a carrier of sphingomyelin, we tested the same sHDL formulation in the sphingomyelin storage disease Niemann\u2013Pick type A. Utilizing stimulated Raman scattering microscopy to detect endogenous unlabeled lipids, we show significant rescue of Niemann\u2013Pick type A lipid storage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, our data establish that sHDL nanoparticles are a potential new therapeutic avenue for Niemann\u2013Pick diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-019-1423-5","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T11:03:38Z","timestamp":1573470218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann\u2013Pick diseases"],"prefix":"10.1186","volume":"17","author":[{"given":"Mark L.","family":"Schultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Fawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth D.","family":"Azaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Hollon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaddeus J.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy A.","family":"Halseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey L.","family":"Krus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley S.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Bushart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram G.","family":"Shakkottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Orringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Schwendeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"issue":"12","key":"1423_CR1","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1212\/WNL.42.12.2286","volume":"42","author":"JJ Higgins","year":"1992","unstructured":"Higgins JJ, Patterson MC, Dambrosia JM, Pikus AT, Pentchev PG, Sato S, Brady RO, Barton NW. A clinical staging classification for type C Niemann-Pick disease. Neurology. 1992;42(12):2286\u201390.","journal-title":"Neurology"},{"issue":"4","key":"1423_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","volume":"64","author":"MT Vanier","year":"2003","unstructured":"Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet. 2003;64(4):269\u201381.","journal-title":"Clin Genet"},{"issue":"9","key":"1423_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/35089558","volume":"2","author":"YA Ioannou","year":"2001","unstructured":"Ioannou YA. Multidrug permeases and subcellular cholesterol transport. Nat Rev Mol Cell Biol. 2001;2(9):657\u201368.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"40","key":"1423_CR4","doi-asserted-by":"publisher","first-page":"15287","DOI":"10.1073\/pnas.0807328105","volume":"105","author":"RE Infante","year":"2008","unstructured":"Infante RE, Wang ML, Radhakrishnan A, Kwon HJ, Brown MS, Goldstein JL. NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc Natl Acad Sci U S A. 2008;105(40):15287\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"1423_CR5","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","volume":"82","author":"PG Pentchev","year":"1985","unstructured":"Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA, Patel S, Brady RO. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci U S A. 1985;82(23):8247\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"1423_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","volume":"120","author":"EH Schuchman","year":"2017","unstructured":"Schuchman EH, Desnick RJ. Types A and B Niemann-Pick disease. Mol Genet Metab. 2017;120(1\u20132):27\u201333.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1423_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MOL.0000000000000050","volume":"25","author":"M Hellerstein","year":"2014","unstructured":"Hellerstein M, Turner S. Reverse cholesterol transport fluxes. Curr Opin Lipidol. 2014;25(1):40\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"9","key":"1423_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1586\/14779072.6.9.1203","volume":"6","author":"AT Remaley","year":"2008","unstructured":"Remaley AT, Amar M, Sviridov D. HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications. Expert Rev Cardiovasc Ther. 2008;6(9):1203\u201315.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"1423_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrd4279","volume":"13","author":"BA Kingwell","year":"2014","unstructured":"Kingwell BA, Chapman MJ, Kontush A, Miller NE. HDL-targeted therapies: progress, failures and future. Nat Rev Drug Discov. 2014;13(6):445.","journal-title":"Nat Rev Drug Discov"},{"issue":"17","key":"1423_CR10","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","volume":"290","author":"SE Nissen","year":"2003","unstructured":"Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. Jama. 2003;290(17):2292\u2013300.","journal-title":"Jama"},{"issue":"15","key":"1423_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","volume":"297","author":"J-C Tardif","year":"2007","unstructured":"Tardif J-C, Gr\u00e9goire J, L\u2019Allier PL, Ibrahim R, Lesp\u00e9rance J, Heinonen TM, Kouz S, Berry C, Basser R, Lavoie M-A. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. Jama. 2007;297(15):1675\u201382.","journal-title":"Jama"},{"issue":"3","key":"1423_CR12","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1021\/acsnano.5b07522","volume":"10","author":"R Kuai","year":"2016","unstructured":"Kuai R, Li D, Chen YE, Moon JJ, Schwendeman A. High-density lipoproteins: nature\u2019s multifunctional nanoparticles. ACS Nano. 2016;10(3):3015\u201341.","journal-title":"ACS Nano"},{"issue":"6","key":"1423_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/MOL.0000000000000020","volume":"24","author":"BR Krause","year":"2013","unstructured":"Krause BR, Remaley AT. Reconstituted HDL for the acute treatment of acute coronary syndrome. Curr Opin Lipidol. 2013;24(6):480\u20136.","journal-title":"Curr Opin Lipidol"},{"issue":"9","key":"1423_CR14","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1194\/jlr.M060285","volume":"56","author":"A Schwendeman","year":"2015","unstructured":"Schwendeman A, Sviridov DO, Yuan W, Guo Y, Morin EE, Yuan Y, Stonik J, Freeman L, Ossoli A, Thacker S, et al. The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties. J Lipid Res. 2015;56(9):1727\u201337.","journal-title":"J Lipid Res"},{"issue":"1","key":"1423_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1194\/jlr.M071043","volume":"58","author":"J Tang","year":"2017","unstructured":"Tang J, Li D, Drake L, Yuan W, Deschaine S, Morin EE, Ackermann R, Olsen K, Smith DE, Schwendeman A. Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization. J Lipid Res. 2017;58(1):124\u201336.","journal-title":"J Lipid Res"},{"issue":"4","key":"1423_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1194\/jlr.M200475-JLR200","volume":"44","author":"AT Remaley","year":"2003","unstructured":"Remaley AT, Thomas F, Stonik JA, Demosky SJ, Bark SE, Neufeld EB, Bocharov AV, Vishnyakova TG, Patterson AP, Eggerman TL. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res. 2003;44(4):828\u201336.","journal-title":"J Lipid Res"},{"issue":"2","key":"1423_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/CIRCRESAHA.110.216507","volume":"107","author":"W D'Souza","year":"2010","unstructured":"D'Souza W, Stonik JA, Murphy A, Demosky SJ, Sethi AA, Moore XL, Chin-Dusting J, Remaley AT, Sviridov D. Structure\/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein. Circ Res. 2010;107(2):217\u201327.","journal-title":"Circ Res"},{"issue":"8","key":"1423_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002171","volume":"4","author":"P Tricoci","year":"2015","unstructured":"Tricoci P, D'Andrea DM, Gurbel PA, Yao Z, Cuchel M, Winston B, Schott R, Weiss R, Blazing MA, Cannon L. Infusion of reconstituted high-density lipoprotein, CSL112, in patients with atherosclerosis: safety and pharmacokinetic results from a phase 2a randomized clinical trial. J Am Heart Assoc. 2015;4(8):e002171.","journal-title":"J Am Heart Assoc"},{"key":"1423_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.phrs.2016.05.001","volume":"111","author":"CL Bisgaier","year":"2016","unstructured":"Bisgaier CL, Ackermann R, Rea T, Rodrigueza WV, Hartman D. ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers. Pharmacol Res. 2016;111:86\u201399.","journal-title":"Pharmacol Res"},{"issue":"5","key":"1423_CR20","first-page":"e-19","volume":"24","author":"J Miles","year":"2004","unstructured":"Miles J, Khan M, Painchaud C, Lalwani N, Drake S, Dasseux J-L. P105 single-dose tolerability, pharmacokinetics, and cholesterol mobilization in Hdl-c fraction following intravenous administration of Etc-642, a 22-mer Apoa-i analogue and phospholipids complex, in atherosclerosis patients. Arteriosclerosis, Thrombosis Vascular Biol J Am Heart Assoc. 2004;24(5):e-19.","journal-title":"Arteriosclerosis, Thrombosis Vascular Biol J Am Heart Assoc"},{"issue":"46","key":"1423_CR21","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","volume":"35","author":"J-C Tardif","year":"2014","unstructured":"Tardif J-C, Ballantyne CM, Barter P, Dasseux J-L, Fayad ZA, Guertin M-C, Kastelein JJ, Keyserling C, Klepp H, Koenig W. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J. 2014;35(46):3277\u201386.","journal-title":"Eur Heart J"},{"issue":"2","key":"1423_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1124\/jpet.110.167890","volume":"334","author":"MJ Amar","year":"2010","unstructured":"Amar MJ, D'Souza W, Turner S, Demosky S, Sviridov D, Stonik J, Luchoomun J, Voogt J, Hellerstein M, Sviridov D, et al. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice. J Pharmacol Exp Ther. 2010;334(2):634\u201341.","journal-title":"J Pharmacol Exp Ther"},{"key":"1423_CR23","doi-asserted-by":"crossref","unstructured":"Bourdi M, Amar M, Remaley AT, Terse PS. Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys. Regul Toxicol Pharmacol. 2018;100:59\u201367.","DOI":"10.1016\/j.yrtph.2018.10.009"},{"issue":"21","key":"1423_CR24","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1523\/JNEUROSCI.4173-14.2015","volume":"35","author":"M Praggastis","year":"2015","unstructured":"Praggastis M, Tortelli B, Zhang J, Fujiwara H, Sidhu R, Chacko A, Chen Z, Chung C, Lieberman AP, Sikora J, et al. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele. J Neurosci. 2015;35(21):8091\u2013106.","journal-title":"J Neurosci"},{"issue":"1","key":"1423_CR25","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1038\/s41467-018-06115-2","volume":"9","author":"ML Schultz","year":"2018","unstructured":"Schultz ML, Krus KL, Kaushik S, Dang D, Chopra R, Qi L, Shakkottai VG, Cuervo AM, Lieberman AP. Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD. Nat Commun. 2018;9(1):3671.","journal-title":"Nat Commun"},{"issue":"8","key":"1423_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/hmg\/ddy050","volume":"27","author":"R Chopra","year":"2018","unstructured":"Chopra R, Wasserman AH, Pulst SM, De Zeeuw CI, Shakkottai VG. Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia. Hum Mol Genet. 2018;27(8):1396\u2013410.","journal-title":"Hum Mol Genet"},{"key":"1423_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","volume":"7","author":"LR Moore","year":"2017","unstructured":"Moore LR, Rajpal G, Dillingham IT, Qutob M, Blumenstein KG, Gattis D, Hung G, Kordasiewicz HB, Paulson HL, McLoughlin HS. Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models. Mol Ther Nucleic Acids. 2017;7:200\u201310.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5909","key":"1423_CR28","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1126\/science.1165758","volume":"322","author":"CW Freudiger","year":"2008","unstructured":"Freudiger CW, Min W, Saar BG, Lu S, Holtom GR, He C, Tsai JC, Kang JX, Xie XS. Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy. Science. 2008;322(5909):1857\u201361.","journal-title":"Science"},{"issue":"8","key":"1423_CR29","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1073\/pnas.72.8.2925","volume":"72","author":"MS Brown","year":"1975","unstructured":"Brown MS, Dana SE, Goldstein JL. Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc Natl Acad Sci. 1975;72(8):2925\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1423_CR30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-2275(20)32045-9","volume":"41","author":"DW Garber","year":"2000","unstructured":"Garber DW, Kulkarni KR, Anantharamaiah G. A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J Lipid Res. 2000;41(6):1020\u20136.","journal-title":"J Lipid Res"},{"issue":"12","key":"1423_CR31","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1161\/ATVBAHA.112.300133","volume":"32","author":"EA Fisher","year":"2012","unstructured":"Fisher EA, Feig JE, Hewing B, Hazen SL, Smith JD. High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol. 2012;32(12):2813\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1423_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0163-7827(01)00020-0","volume":"41","author":"H Ohvo-Rekil\u00e4","year":"2002","unstructured":"Ohvo-Rekil\u00e4 H, Ramstedt B, Leppim\u00e4ki P, Slotte JP. Cholesterol interactions with phospholipids in membranes. Prog Lipid Res. 2002;41(1):66\u201397.","journal-title":"Prog Lipid Res"},{"issue":"2","key":"1423_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0006-3495(99)77254-1","volume":"76","author":"B Ramstedt","year":"1999","unstructured":"Ramstedt B, Slotte JP. Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain length. Biophys J. 1999;76(2):908\u201315.","journal-title":"Biophys J"},{"issue":"2","key":"1423_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2011.04.001","volume":"217","author":"BA Di Bartolo","year":"2011","unstructured":"Di Bartolo BA, Nicholls SJ, Bao S, Rye KA, Heather AK, Barter PJ, Bursill C. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis. 2011;217(2):395\u2013400.","journal-title":"Atherosclerosis"},{"key":"1423_CR35","doi-asserted-by":"publisher","unstructured":"Li D, Gordon S, Schwendeman A, Remaley AT. Apolipoprotein mimetic peptides for stimulating cholesterol efflux. In: Anantharamaiah G, Goldberg D (eds). Apolipoprotein Mimetics in the Management of Human Disease. Adis: Springer; 2015:29\u201342. https:\/\/doi.org\/10.1007\/978-3-319-17350-4_3.","DOI":"10.1007\/978-3-319-17350-4_3"},{"issue":"5248","key":"1423_CR36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1126\/science.271.5248.518","volume":"271","author":"S Acton","year":"1996","unstructured":"Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 1996;271(5248):518\u201320.","journal-title":"Science"},{"issue":"8","key":"1423_CR37","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1194\/jlr.R047837","volume":"55","author":"JE Vance","year":"2014","unstructured":"Vance JE, Karten B. Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin. J Lipid Res. 2014;55(8):1609\u201321.","journal-title":"J Lipid Res"},{"issue":"12","key":"1423_CR38","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1073\/pnas.0914309107","volume":"107","author":"AI Rosenbaum","year":"2010","unstructured":"Rosenbaum AI, Zhang G, Warren JD, Maxfield FR. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells. Proc Natl Acad Sci U S A. 2010;107(12):5477\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"1423_CR39","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1523\/JNEUROSCI.0900-16.2016","volume":"36","author":"V Demais","year":"2016","unstructured":"Demais V, Barthelemy A, Perraut M, Ungerer N, Keime C, Reibel S, Pfrieger FW. Reversal of pathologic lipid accumulation in NPC1-deficient neurons by drug-promoted release of LAMP1-coated lamellar inclusions. J Neurosci. 2016;36(30):8012\u201325.","journal-title":"J Neurosci"},{"issue":"12","key":"1423_CR40","doi-asserted-by":"publisher","first-page":"9290","DOI":"10.1074\/jbc.M111.326405","volume":"287","author":"KB Peake","year":"2012","unstructured":"Peake KB, Vance JE. Normalization of cholesterol homeostasis by 2-hydroxypropyl-beta-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice. J Biol Chem. 2012;287(12):9290\u20138.","journal-title":"J Biol Chem"},{"issue":"13","key":"1423_CR41","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1074\/jbc.M708735200","volume":"283","author":"ME Gelsthorpe","year":"2008","unstructured":"Gelsthorpe ME, Baumann N, Millard E, Gale SE, Langmade SJ, Schaffer JE, Ory DS. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding. J Biol Chem. 2008;283(13):8229\u201336.","journal-title":"J Biol Chem"},{"issue":"14","key":"1423_CR42","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1093\/hmg\/dds145","volume":"21","author":"T Yu","year":"2012","unstructured":"Yu T, Chung C, Shen D, Xu H, Lieberman AP. Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts. Hum Mol Genet. 2012;21(14):3205\u201314.","journal-title":"Hum Mol Genet"},{"issue":"15","key":"1423_CR43","doi-asserted-by":"publisher","first-page":"15571","DOI":"10.1074\/jbc.M314160200","volume":"279","author":"EB Neufeld","year":"2004","unstructured":"Neufeld EB, Stonik JA, Demosky SJ Jr, Knapper CL, Combs CA, Cooney A, Comly M, Dwyer N, Blanchette-Mackie J, Remaley AT, et al. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem. 2004;279(15):15571\u20138.","journal-title":"J Biol Chem"},{"issue":"2","key":"1423_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2443.2008.01261.x","volume":"14","author":"Y Azuma","year":"2009","unstructured":"Azuma Y, Takada M, Shin HW, Kioka N, Nakayama K, Ueda K. Retroendocytosis pathway of ABCA1\/apoA-I contributes to HDL formation. Genes Cells. 2009;14(2):191\u2013204.","journal-title":"Genes Cells"},{"issue":"4","key":"1423_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.200908086","volume":"188","author":"M Koivusalo","year":"2010","unstructured":"Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol. 2010;188(4):547\u201363.","journal-title":"J Cell Biol"},{"issue":"11","key":"1423_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015054","volume":"5","author":"FW Chen","year":"2010","unstructured":"Chen FW, Li C, Ioannou YA. Cyclodextrin induces calcium-dependent lysosomal exocytosis. PLoS One. 2010;5(11):e15054.","journal-title":"PLoS One"},{"issue":"2","key":"1423_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00227765","volume":"85","author":"Y Higashi","year":"1993","unstructured":"Higashi Y, Murayama S, Pentchev PG, Suzuki K. Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol. 1993;85(2):175\u201384.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1423_CR48","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/hmg\/ddp552","volume":"19","author":"MJ Elrick","year":"2010","unstructured":"Elrick MJ, Pacheco CD, Yu T, Dadgar N, Shakkottai VG, Ware C, Paulson HL, Lieberman AP. Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration. Hum Mol Genet. 2010;19(5):837\u201347.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1423_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cbi.2009.04.012","volume":"180","author":"IL Aye","year":"2009","unstructured":"Aye IL, Singh AT, Keelan JA. Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability and function. Chem Biol Interact. 2009;180(3):327\u201339.","journal-title":"Chem Biol Interact"},{"issue":"2\u20133","key":"1423_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1388-1981(00)00006-8","volume":"1484","author":"ND Ridgway","year":"2000","unstructured":"Ridgway ND. Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochim Biophys Acta. 2000;1484(2\u20133):129\u201341.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1423_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1073\/pnas.55.2.366","volume":"55","author":"RO Brady","year":"1966","unstructured":"Brady RO, Kanfer JN, Mock MB, Fredrickson DS. The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci U S A. 1966;55(2):366\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1423_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006951","volume":"4","author":"CD Davidson","year":"2009","unstructured":"Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, Dobrenis K, Ory DS, Vanier MT, Walkley SU. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One. 2009;4(9):e6951.","journal-title":"PLoS One"},{"issue":"46","key":"1423_CR53","doi-asserted-by":"publisher","first-page":"18065","DOI":"10.1523\/JNEUROSCI.0498-13.2013","volume":"33","author":"L Tecedor","year":"2013","unstructured":"Tecedor L, Stein CS, Schultz ML, Farwanah H, Sandhoff K, Davidson BL. CLN3 loss disturbs membrane microdomain properties and protein transport in brain endothelial cells. J Neurosci. 2013;33(46):18065\u201379.","journal-title":"J Neurosci"},{"key":"1423_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.nbd.2018.04.010","volume":"115","author":"ML Schultz","year":"2018","unstructured":"Schultz ML, Tecedor L, Lysenko E, Ramachandran S, Stein CS, Davidson BL. Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo. Neurobiol Dis. 2018;115:182\u201393.","journal-title":"Neurobiol Dis"},{"key":"1423_CR55","doi-asserted-by":"publisher","unstructured":"Orringer DA, Pandian B, Niknafs YS, Hollon TC, Boyle J, Lewis S, Garrard M, Hervey-Jumper SL, Garton HJL, Maher CO, et al. Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopy. Nat Biomed Eng. 2017;1. https:\/\/doi.org\/10.1038\/s41551-016-0027.","DOI":"10.1038\/s41551-016-0027"},{"issue":"35","key":"1423_CR56","doi-asserted-by":"publisher","first-page":"32569","DOI":"10.1074\/jbc.M304553200","volume":"278","author":"HY Choi","year":"2003","unstructured":"Choi HY, Karten B, Chan T, Vance JE, Greer WL, Heidenreich RA, Garver WS, Francis GA. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J Biol Chem. 2003;278(35):32569\u201377.","journal-title":"J Biol Chem"},{"issue":"10","key":"1423_CR57","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1194\/jlr.M700056-JLR200","volume":"48","author":"TA Pagler","year":"2007","unstructured":"Pagler TA, Neuhofer A, Laggner H, Strobl W, Stangl H. Cholesterol efflux via HDL resecretion occurs when cholesterol transport out of the lysosome is impaired. J Lipid Res. 2007;48(10):2141\u201350.","journal-title":"J Lipid Res"},{"issue":"3","key":"1423_CR58","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1194\/jlr.M500487-JLR200","volume":"47","author":"CY Lee","year":"2006","unstructured":"Lee CY, Lesimple A, Denis M, Vincent J, Larsen A, Mamer O, Krimbou L, Genest J, Marcil M. Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B. J Lipid Res. 2006;47(3):622\u201332.","journal-title":"J Lipid Res"},{"issue":"8","key":"1423_CR59","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jmg.27.8.499","volume":"27","author":"MB Viana","year":"1990","unstructured":"Viana MB, Giugliani R, Leite VH, Barth ML, Lekhwani C, Slade CM, Fensom A. Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann-Pick disease and sea-blue histiocytosis. J Med Genet. 1990;27(8):499\u2013504.","journal-title":"J Med Genet"},{"issue":"2","key":"1423_CR60","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1194\/jlr.P000331","volume":"51","author":"WS Garver","year":"2010","unstructured":"Garver WS, Jelinek D, Meaney FJ, Flynn J, Pettit KM, Shepherd G, Heidenreich RA, Vockley CM, Castro G, Francis GA. The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes. J Lipid Res. 2010;51(2):406\u201315.","journal-title":"J Lipid Res"},{"issue":"48","key":"1423_CR61","doi-asserted-by":"publisher","first-page":"37081","DOI":"10.1074\/jbc.M606890200","volume":"281","author":"E Boadu","year":"2006","unstructured":"Boadu E, Choi HY, Lee DW, Waddington EI, Chan T, Asztalos B, Vance JE, Chan A, Castro G, Francis GA. Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts. J Biol Chem. 2006;281(48):37081\u201390.","journal-title":"J Biol Chem"},{"issue":"3","key":"1423_CR62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbalip.2011.11.013","volume":"1821","author":"E Boadu","year":"2012","unstructured":"Boadu E, Nelson RC, Francis GA. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein. Biochim Biophys Acta. 2012;1821(3):396\u2013404.","journal-title":"Biochim Biophys Acta"},{"issue":"47","key":"1423_CR63","doi-asserted-by":"publisher","first-page":"43564","DOI":"10.1074\/jbc.M107938200","volume":"276","author":"W Chen","year":"2001","unstructured":"Chen W, Sun Y, Welch C, Gorelik A, Leventhal AR, Tabas I, Tall AR. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes\/lysosomes. J Biol Chem. 2001;276(47):43564\u20139.","journal-title":"J Biol Chem"},{"key":"1423_CR64","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2018.06.881","volume":"275","author":"P Zanoni","year":"2018","unstructured":"Zanoni P, Velagapudi S, Yalcinkaya M, Rohrer L, von Eckardstein A. Endocytosis of lipoproteins. Atherosclerosis. 2018;275:273\u201395.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1423_CR65","first-page":"270","volume":"61","author":"K Takahashi","year":"1989","unstructured":"Takahashi K, Fukuda S, Naito M, Horiuchi S, Takata K, Morino Y. Endocytic pathway of high density lipoprotein via trans-Golgi system in rat resident peritoneal macrophages. Lab Investig. 1989;61(3):270\u20137.","journal-title":"Lab Investig"},{"issue":"8","key":"1423_CR66","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1194\/jlr.M500450-JLR200","volume":"47","author":"B Sun","year":"2006","unstructured":"Sun B, Eckhardt ER, Shetty S, van der Westhuyzen DR, Webb NR. Quantitative analysis of SR-BI-dependent HDL retroendocytosis in hepatocytes and fibroblasts. J Lipid Res. 2006;47(8):1700\u201313.","journal-title":"J Lipid Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1423-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T15:09:58Z","timestamp":1612278598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1423-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal studies were approved by the University of Michigan Committee on Use and Care of Animals (PRO00008133).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}